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Dynamic actin remodeling during epithelial–
mesenchymal transition depends on increased 
moesin expression
Jennifer Haynes, Jyoti Srivastava, Nikki Madson, Torsten Wittmann, and Diane L. Barber
Department of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA 94143
ABSTRACT Remodeling of actin filaments is necessary for epithelial–mesenchymal transition 
(EMT); however, understanding of how this is regulated in real time is limited. We used an 
actin filament reporter and high-resolution live-cell imaging to analyze the regulated dynam-
ics of actin filaments during transforming growth factor-β–induced EMT of mammary epithe-
lial cells. Progressive changes in cell morphology were accompanied by reorganization of 
actin filaments from thin cortical bundles in epithelial cells to thick, parallel, contractile bun-
dles that disassembled more slowly but remained dynamic in transdifferentiated cells. We 
show that efficient actin filament remodeling during EMT depends on increased expression 
of the ezrin/radixin/moesin (ERM) protein moesin. Cells suppressed for moesin expression by 
short hairpin RNA had fewer, thinner, and less stable actin bundles, incomplete morphologi-
cal transition, and decreased invasive capacity. These cells also had less α-smooth muscle ac-
tin and phosphorylated myosin light chain in cortical patches, decreased abundance of the 
adhesion receptor CD44 at membrane protrusions, and attenuated autophosphorylation of 
focal adhesion kinase. Our findings suggest that increased moesin expression promotes EMT 
by regulating adhesion and contractile elements for changes in actin filament organization. 
We propose that the transciptional program driving EMT controls progressive remodeling of 
actin filament architectures.
INTRODUCTION
Epithelial–mesenchymal transition (EMT) is a transcriptional and 
morphological program that occurs during normal development 
and tissue remodeling and in the progression of diseases such as 
fibrosis and metastatic cancers. As a process of epithelial plasticity, 
EMT is achieved when epithelial cell–cell adhesions are dissolved, 
the actin cytoskeleton is reorganized, and cells acquire increased 
cell–matrix contacts and enhanced migratory and invasive capabili-
ties (Xu et al., 2009; Yilmaz and Christofori, 2009). The most recog-
nized inducers of EMT are growth factors acting through receptor 
tyrosine kinases, secreted signaling molecules in the Wnt and Notch 
families, and cytokines, such as transforming growth factor-β (TGF-β) 
(Moustakas and Heldin, 2007). The transcriptional program for EMT 
induced by TGF-β is well characterized and is coordinated primarily 
through Smad-dependent activation of transcription factors of the 
Snail, ZEB, and Twist families (Xu et al., 2009). These transcription 
factors drive EMT by repressing expression of epithelial genes and 
activating expression of mesenchymal genes. Down-regulated 
genes include those encoding proteins maintaining epithelial cell–
cell adhesions, such as the adherens junction protein E-cadherin, 
and the tight junctions proteins claudins and occludin. Up-regulated 
genes include those encoding proteins promoting cell migration 
and invasion, such as the mesenchymal cell–cell adhesion protein 
N-cadherin, the intermediate filament protein vimentin, and the ex-
tracellular matrix proteins fibronectin and collagen.
In contrast with the transcriptional program controlling transdif-
ferentiation and morphological changes during EMT, dynamic re-
modeling of the actin cytoskeleton and how this is regulated are less 
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cortical thin bundles. In contrast, actin filaments in transdifferenti-
ated mesenchymal cells are bundled into thick contractile stress fi-
bers at the ventral cell surface. For TGF-β–induced EMT, actin cy-
toskeleton remodeling requires activation of the guanosine 
triphosphatase (GTPase) RhoA, which also is necessary to disrupt 
localization of E-cadherin at cell–cell adhesions and to promote a 
mesenchymal cell morphology (Bhowmick et al., 2001; Tavares 
et al., 2006; Cho and Yoo, 2007). Inactivation of the RhoA effector, 
Rho-associated coiled-coil–containing protein kinase (ROCK), inhib-
its TGF-β–dependent assembly of actin filaments into stress fibers 
but not delocalization of E-cadherin (Bhowmick et al., 2001; Edlund 
et al., 2002; Masszi et al., 2003). Although a TGF-β–dependent in-
crease in RhoA expression is reported to be necessary for EMT dur-
ing embryonic chick heart development (Tavares et al., 2006), 
changes in RhoA expression have not been identified during EMT 
of cultured cells. Genome-wide expression studies of cell culture 
models of TGF-β–induced EMT indicate that genes encoding actin 
cytoskeleton–associated proteins are consistently upregulated 
(Zavadil et al., 2001; Xie et al., 2003; Valcourt et al., 2005; 
Keshamouni et al., 2006). However, the functional significance of 
this increased expression and whether actin cytoskeleton remodel-
ing by proteins other than RhoA and ROCK are necessary for EMT 
are not known. Because remodeling of the actin cytoskeleton pro-
motes morphological changes and cell migration during EMT and is 
also required for metastatic cancers to spread from primary tumors, 
factors controlling actin cytoskeleton remodeling are potentially key 
targets for therapeutics to restrict cancer progression.
We therefore asked two questions. First, how does dynamic re-
modeling of the actin cytoskeleton occur in real time during EMT? 
Second, does EMT and associated cytoskeleton remodeling de-
pend on changes in the expression of actin regulatory proteins? In 
this study, we used high-resolution live-cell imaging of a fluorescent 
actin filament reporter to reveal regulated dynamics of filament re-
modeling during TGF-β–induced EMT of mouse mammary epithe-
lial cells. We also report that increased expression of moesin, a 
member of the ezrin/radixin/moesin (ERM) family of actin-binding 
proteins, was necessary for efficient EMT. ERM proteins regulate cell 
morphology, migration, and adhesion by cross-linking actin fila-
ments to plasma membrane proteins (Fievet et al., 2007; Fehon 
et al., 2010). Although the function of ERM proteins is often viewed 
as redundant, we found a distinct role for increased moesin in EMT 
that is not shared by ezrin or radixin. Our data show that during EMT 
increased moesin expression is necessary for efficient actin filament 
remodeling, including the stability of contractile actin filament bun-
dles, and for cortical relocalization of adhesion and contractile ele-
ments, including CD44, α-smooth muscle actin (α-SMA), and phos-
phorylated myosin light chain (p-MLC). Moreover, our findings 
reveal a link between the transcriptional program of EMT and actin 
filament remodeling during transdifferentiation.
RESULTS
Dynamic changes in cell morphology and actin filament 
organization during TGF-β–induced EMT
To initially characterize the dynamics of cell morphological changes 
during EMT, we used phase contrast time-lapse microscopy over 
48 h to observe mouse mammary epithelial NMuMG cells that were 
previously reported to undergo transdifferentiation with TGF-β 
treatment (Miettinen et al., 1994; Bakin et al., 2000; Bhowmick et al., 
2001; Lamouille and Derynck, 2007). Untreated NMuMG epithelial 
cells were cuboidal shaped and organized in compact islets 
(Figure 1A and Supplemental Video S1). After ∼10 h with TGF-β, 
cells in these islets became more loosely arranged, and after ∼12 h 
they started to elongate. These changes progressed gradually to a 
spindle-shaped morphology with cells arranged in parallel, which 
was evident at ∼24 h with TGF-β, although cells elongated further 
between 24 and 48 h.
Changes in cell morphology corresponded with reorganization 
of filamentous actin (F-actin). In NMuMG cells maintained in the ab-
sence of TGF-β, phalloidin-labeled F-actin was predominantly orga-
nized in cortical bundles tightly associated with cell–cell adhesions 
(Figure 1B), as previously described (Miettinen et al., 1994). In con-
trast, after 48 h with TGF-β, F-actin was assembled into thick parallel 
bundles, or actin stress fibers, traversing the ventral cell surface. To 
characterize the dynamics of actin filament remodeling during EMT, 
we transiently expressed green fluorescent protein (GFP)–tagged 
LifeAct in NMuMG cells. LifeAct is a yeast F-actin–binding peptide 
that does not interfere with actin dynamics and has been used to 
visualize F-actin in live cells (Riedl et al., 2008), but its use during 
EMT has not been reported. In NMuMG cells maintained in the ab-
sence or presence of TGF-β for 48 h, LifeAct-GFP colabeled F-actin 
stained with rhodamine-phalloidin (Figure 1C) and did not disrupt 
actin filament remodeling, which validates its use as a reporter of 
actin filament dynamics during EMT.
We used spinning disk confocal fluorescence time-lapse micros-
copy to monitor actin filament dynamics in live cells undergoing 
TGF-β–induced EMT. Because long-term fluorescent imaging is 
technically challenging, we observed a time window between 6 and 
33 h after treatment with TGF-β and focused on the ventral cell 
surface, where stress fibers assemble and where we expected the 
most dramatic changes in F-actin organization to occur (Figure 1B). 
We did not observe a rapid switch in actin filament organization but 
instead found a slow and progressive increase in the number, width, 
and length of actin filaments that occurred in parallel with changes 
in cell morphology (Figure 1D and Supplemental Video S2). By 
∼24 h with TGF-β, most cells had assembled thick contractile actin 
stress fibers. To analyze the dynamics of these actin stress fibers, we 
imaged cells expressing LifeAct-GFP after treatment with TGF-β for 
24 or 48 h at a higher time resolution. Actin stress fibers further in-
creased in number and size between 24 and 48 h with TGF-β (Figure 
1E and Supplemental Videos S3 and S4). By 48 h with TGF-β, stress 
fibers appeared thicker and more bundled and remained assembled 
longer compared with earlier time points but they remained dy-
namic and contractile (Figure 1F). In contrast, untreated cells ex-
pressing LifeAct-GFP retained a randomly organized network of 
thin, short, noncontractile actin filaments at the basal surface (Figure 
1E and Supplemental Video S5). In addition to actin filament remod-
eling, these time-lapse movies also indicated a decrease in the num-
ber of membrane protrusions with TGF-β treatment. Thus, the 
marked changes in cell morphology that occur during TGF-β–
induced EMT are accompanied by a progressive and dynamic re-
modeling of the actin cytoskeleton that includes distinct changes in 
actin stress fiber bundling and contractility and fewer membrane 
protrusions.
ERM protein expression changes during 
TGF-β–induced EMT
EMT is a transcriptional program that down-regulates expression of 
epithelial genes and up-regulates expression of mesenchymal 
genes. TGF-β–induced EMT of NMuMG cells was accompanied by 
a gradual decrease in the abundance of the epithelial cell–cell 
adhesion protein E-cadherin and an increase in the abundance of 
the mesenchymal adhesion protein N-cadherin (Figure 2A), as 
previously shown (Miettinen et al., 1994; Bhowmick et al., 2001). 
The slow and progressive changes in cell morphology and actin 
4752 | J. Haynes et al. Molecular Biology of the Cell
FiGuRE 1: Morphological changes and actin cytoskeleton remodeling during TGF-β–induced EMT of mouse mammary 
epithelial NMuMG cells. (A) Images of cells treated with TGF-β for the indicated times showing morphological changes 
during EMT. Images were acquired by phase contrast, time-lapse microscopy using a 40× objective. Bar, 20 μm. See 
Supplemental Video S1. (B) Rhodamine-phalloidin labeling of F-actin in cells maintained in the absence or presence of 
TGF-β for 48 h. Images show F-actin staining for cells at a single Z-section (bottom, middle, or top), or a maximum-
intensity projection of multiple Z-sections. Bar, 20 μm. (C) F-actin labeling of cells expressing LifeAct-GFP maintained in 
the absence or presence of TGF-β for 48 h and stained with rhodamine-phalloidin after fixing. Bar, 20 μm. (D–F) Images 
of cells expressing LifeAct-GFP and treated with TGF-β for the indicated times. Images were acquired by spinning disk 
confocal time-lapse microscopy using a 60× objective to show dynamic remodeling of the actin cytoskeleton during 
EMT. Bars, 20 μm. (D) Cells were imaged from 6 to 33 h after TGF-β treatment. Images are displayed with a γ value of 
0.9 to enhance dim features. See Supplemental Video S2. (E) Cells were imaged for 1 h, beginning at 24 or 48 h after 
TGF-β treatment. Untreated cells were imaged after 48 h with vehicle control. See Supplemental Videos S3–S5. 
(F) Boxed region in E magnified and shown as a montage of images that were captured every 5 min.
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cytoskeleton remodeling during EMT suggested transcriptional 
regulation of genes encoding proteins that control actin filament 
organization rather than rapid signaling events. To test this, we ana-
lyzed the expression levels of ERM proteins ezrin, radixin, and 
moesin, which bind actin filaments and have an established role in 
epithelial cell morphology (Fehon et al., 2010). Immunoblotting 
with specific as well as pan-ERM antibodies showed that the abun-
dance of ezrin decreased, whereas the 
abundance of moesin increased, as early as 
24 h after TGF-β treatment (Figure 2B). In 
contrast, the abundance of radixin was un-
changed (Figure 2C). After 3 d with TGF-β, 
ezrin protein levels decreased 2.7-fold (p < 
0.001; n = 3) and moesin protein levels in-
creased 2.3-fold (p < 0.001; n = 3; Figure 
2D). Increased abundance of moesin was 
sustained for up to 7 d with TGF-β (unpub-
lished data). Consistent with our immunob-
lot data, quantitative PCR (qPCR) analysis 
showed that changes in ezrin and moesin 
protein expression were preceded by 
changes in gene expression (Figure 2E). Af-
ter 48 h with TGF-β, ezrin mRNA levels de-
creased 2.8-fold (p < 0.01; n = 4) and moesin 
mRNA levels increased 5.2-fold (p < 0.01; 
n = 4). Furthermore, qPCR analysis revealed 
that by 48 h with TGF-β, moesin was the 
most abundant ERM mRNA expressed 
(78%), compared with untreated control 
cells, in which ezrin was predominant (59%). 
These opposing changes in expression of 
ezrin and moesin indicate that ERM protein 
switching occurs during the initial stages of 
TGF-β–induced EMT and suggest that ERM 
proteins may have nonredundant functions.
In addition to increased expression, 
changes in moesin localization were ob-
served during EMT. In NMuMG cells main-
tained in the absence of TGF-β, moesin 
immunolabeling was localized at the apical 
membrane, associated with microvilli at the 
apical surface and concentrated at cell–cell 
adhesions (Figure 2F). In contrast, after 48 h 
with TGF-β, immunolabeling was predomi-
nantly localized at distinct large membrane 
protrusions on the dorsal cell surface and 
was also found at filopodia extending from 
the ventral cell surface. Consistent with its 
known role as a membrane–cytoskeleton 
linker, moesin colocalized with the plasma 
membrane and membrane-associated F-
actin, as indicated by wheat germ agglutinin 
and phalloidin labeling, respectively (Sup-
plemental Figure S1).
We also confirmed that changes in 
moesin and ezrin protein expression during 
EMT were reversible, by treating transdiffer-
entiated NMuMG cells with the TGF-β type 
I receptor inhibitor SB431542, which in-
duces mesenchymal–epithelial transition 
(MET; Halder et al., 2005). We confirmed 
MET of transdifferentiated cells treated with 
SB431542 for 2–3 d, as indicated by morphological changes from 
mesenchymal to epithelial (unpublished data) and increased abun-
dance of E-cadherin protein (Figure 2G). In the presence of 
SB431542, the abundance of ezrin increased and the abundance of 
moesin decreased. These data show that ezrin and moesin expres-
sion in NMuMG cells is dynamically and reversibly regulated during 
transdifferentiation.
FiGuRE 2: Expression of the ERM proteins ezrin and moesin changes during TGF-β–induced 
EMT. (A–C) Immunoblots of lysates from NMuMG cells treated with TGF-β for the indicated 
times, showing changes in protein expression during EMT. Cells were maintained in the absence 
(−) or presence (+) of TGF-β for the indicated times. Blots were probed with E-cadherin– and 
N-cadherin–specific antibodies (A), ezrin- and moesin-specific and pan-ERM antibodies (B), and 
radixin-specific antibodies (C). Blots were also probed with antibodies for β-actin as a loading 
control. (D) Relative abundance of ezrin and moesin proteins in TGF-β–treated samples 
compared with untreated control samples was determined by semiquantitative densitometry of 
anti-ezrin and anti-moesin immunoblots. Data shown are means ± SEM of three independent cell 
preparations. (E) qPCR analysis of mRNA from NMuMG cells treated with TGF-β, showing 
changes in gene expression during EMT. Cells were maintained in the absence or presence of 
TGF-β for the indicated times. Relative mRNA expression for ezrin, moesin, and radixin in 
TGF-β–treated samples compared with untreated control samples was determined by qPCR and 
normalized to Rpl19 mRNA expression. Data shown are means ± SEM of at least three 
independent cell preparations. (F) Moesin immunolabeling, showing changes in localization 
during EMT. Cells were maintained in the absence or presence TGF-β for 48 h. Fixed cells were 
labeled with antibodies specific for moesin. Images show maximum-intensity projections of 
multiple Z-sections. Bar, 20 μm. (G) Immunoblots showing that ezrin and moesin expression is 
reversed during MET. Cells were maintained in the absence (−) or presence (+) of TGF-β for the 
indicated times to induce EMT and then cotreated with the TGF-β type I receptor inhibitor 
compound SB431542 in the absence or presence of TGF-β for the indicated times to induce 
MET. Blots were probed with E-cadherin and with ezrin- and moesin-specific antibodies. Blots 
were also probed with antibodies for β-actin as a loading control.
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We next tested whether changes in ezrin and moesin expression 
are conserved during EMT in other cell types. Human mammary 
epithelial MCF-10A cells undergo EMT in 2–6 d when treated with 
TGF-β (Brown et al., 2004; Maeda et al., 2005). As expected, this 
was accompanied by morphological changes from epithelial to 
mesenchymal (unpublished data) and by increased abundance of 
the extracellular matrix protein fibronectin, a mesenchymal marker 
(Figure 3A). The abundance of moesin also increased, similar to 
what we observed during EMT of NMuMG cells. In contrast to 
NMuMG cells, however, there was no change in the abundance of 
ezrin and E-cadherin. During TGF-β–induced EMT of human lung 
adenocarcinoma A549 cells, which down-regulate E-cadherin ex-
pression (Kasai et al., 2005), the abundance of moesin and fibronec-
tin increased, similar to MCF-10A cells. However, although the 
abundance of E-cadherin decreased, the abundance of ezrin was 
unchanged. These data suggest that increased expression of moesin 
is a conserved feature of TGF-β–induced EMT. Whether decreased 
expression of ezrin observed in NMuMG cells occurs in cell types 
other than MCF-10A or A549 cells remains to be determined.
increased moesin expression contributes to morphological 
changes and actin filament remodeling during EMT
To determine the functional significance of increased moesin during 
EMT, we suppressed moesin expression by infecting NMuMG cells 
with lentivirus expressing moesin-specific short hairpin RNA (shRNA) 
sequences. We selected stable clones having the greatest and most 
homogeneous knockdown of moesin, as determined by immunob-
lotting and immunolabeling, respectively (unpublished data). Con-
trol cells expressing nonsilencing shRNA sequences (control shRNA) 
showed changes in protein expression during EMT similar to those 
seen in wild-type cells, including decreased expression of E-cad-
herin and ezrin, and increased expression of N-cadherin and moesin 
(Figure 4A). Two clones of epithelial cells expressing moesin-specific 
shRNAs (moesin shRNA) had ∼80% less moesin but no change in 
the abundance of ezrin (Figure 4A). After 48 h with TGF-β, these 
cells had decreased abundance of E-cadherin and ezrin and in-
creased abundance of N-cadherin, similar to wild-type and control 
shRNA cells. The abundance of moesin increased slightly, although 
total protein expression was still markedly less than with control 
cells.
Moesin shRNA cells treated with TGF-β had distinct differences 
in cell morphology and actin filament organization compared with 
wild-type and control shRNA cells. Although E-cadherin was down-
regulated (Figure 4A) and delocalized from cell–cell adhesions 
(Figure 4B), quantitative morphometric analysis showed that moesin 
shRNA cells did not reach a full morphological transition and were 
significantly less elongated than control shRNA cells (Figure 4C; 
p < 0.01). In addition, moesin shRNA cells had markedly fewer actin 
stress fibers, and bundled filaments were thinner, shorter, and less 
uniformly aligned along the major cell axes (Figure 4B). However, 
abundant thick and parallel stress fibers were observed in moesin 
shRNA cells transiently expressing moesin-GFP that is not targeted 
by moesin shRNA sequences (Supplemental Figure S2). These cells 
were also more elongated, but no differences in actin filaments or 
cell morphology occurred with expression of GFP alone (unpub-
lished data). Moreover, when treated with a fourfold lower concen-
tration of TGF-β for 24 h, moesin shRNA cells had no actin stress fi-
bers, although short, bundled fibers were present in control shRNA 
cells (Figure 4D). To compare these data with the established regu-
lation of actin cytoskeleton organization by ROCK during EMT, we 
treated cells with Y-27632, a pharmacological inhibitor of ROCK ac-
tivity. Actin stress fibers were absent in wild-type cells treated with 
both TGF-β and Y-27632, although E-cadherin was delocalized from 
cell–cell adhesions as in control cells (Figure 4B). This is consistent 
with previous reports that inhibiting ROCK activity specifically blocks 
actin stress fiber formation without affecting dissolution of cell–cell 
adhesions during EMT (Bhowmick et al., 2001; Masszi et al., 2003; 
Hutchison et al., 2009). Our data indicate that increased moesin ex-
pression during EMT promotes the acquisition of a mesenchymal 
morphology and increased number and size of actin stress fibers.
Transdifferentiated cells with suppressed moesin expression 
also had impaired actin stress fiber dynamics. After treatment with 
TGF-β for 48 h, actin filaments in cells transiently expressing Life-
Act-GFP assembled into stress fibers with varying degrees of thick-
ness, stability, and movement. Approximately 40% of wild-type 
and control shRNA cells contained mainly thick, bundled actin 
stress fibers, and only ∼10% of cells had mostly thin fibers (Figure 
5, A–C, and Supplemental Video S6). In contrast, only 5% of 
moesin shRNA cells had mainly thick fibers, whereas 55% of cells 
had mostly thin or no fibers (Figure 5, A–C, and Supplemental 
Video S7). The thick stress fiber bundles were generally aligned 
along the major cell axis, as seen with phalloidin labeling, and 
FiGuRE 3: Increased expression of moesin during TGF-β–induced 
EMT is conserved in human cell lines. Immunoblots of lysates from 
cells treated with TGF-β for the indicated times, showing changes in 
protein expression during EMT. (A) MCF-10A cells were maintained in 
the absence (−) or presence (+) of TGF-β for 3–5 d. Blots were probed 
with antibodies for fibronectin, E-cadherin, ezrin, and moesin. Blots 
were also probed with antibodies for β-actin as a loading control. 
(B) A549 cells were maintained in the absence (−) or presence (+) of 
TGF-β for 1–2 d. Blots were probed with antibodies for fibronectin, 
E-cadherin, ezrin, and moesin. Blots were also probed with antibodies 
for α-tubulin as a loading control.
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often appeared by lateral fusion of thinner fibers. Conversely, thick 
bundles often dissolved by spreading into a less tightly bundled 
array of thin fibers. This complexity of stress fiber dynamics made 
it difficult to quantitatively compare control and moesin shRNA 
cells. Qualitatively, however, actin stress fiber bundles appeared 
more stable in control cells, and although these bundles changed 
structure over time, they often remained visible for the duration of 
the movie (60 min). In contrast, the thin stress fiber bundles ob-
served in moesin shRNA cells were shorter lived and were also less 
uniformly aligned compared with the thick stress fibers in control 
FiGuRE 4: Moesin shRNA knockdown attenuates actin stress fiber assembly and full morphological transition during 
TGF-β–induced EMT. (A) Immunoblots of lysates from NMuMG cells treated with TGF-β, showing changes in protein 
expression during EMT. Wild-type (WT), control shRNA, and moesin shRNA cells were maintained in the absence (–) or 
presence (+) of TGF-β for 48 h. Blots were probed with antibodies for E-cadherin, N-cadherin, moesin, and ezrin. Blots 
were also probed with antibodies for β-actin and α-tubulin as loading controls. (B) E-cadherin immunolabeling and 
F-actin staining of cells, showing changes in organization of cell–cell adhesions and actin cytoskeleton during EMT. 
Wild-type, control shRNA, and moesin shRNA cells were maintained in the absence (–) or presence (+) of TGF-β 
(5 ng/ml) for 48 h. Also shown are wild-type cells cotreated with the ROCK inhibitor Y-27632. Fixed cells were labeled 
with antibodies for E-cadherin and with rhodamine-phalloidin. Arrows indicate cells having fewer, thinner, or absent 
actin stress fibers. Bar, 20 μm. (C) Quantitative analysis of cell morphology of TGF-β–treated cells in B, showing that the 
degree of elongated cell morphology, or morphological index, is reduced in moesin shRNA knockdown cells. Horizontal 
lines indicate the mean value for each cell type. Representative data shown are from a single experiment, for which n 
was between 30 and 40 for each cell type. Similar data were obtained from two independent cell preparations. 
**p < 0.01 by one-way ANOVA followed by Dunnett’s post test. (D) F-actin staining, showing impaired assembly of actin 
stress fibers in moesin shRNA knockdown cells. Control shRNA and moesin shRNA cells were maintained in the absence 
(−) or presence (+) of a low concentration of TGF-β (1.25 ng/ml) for 24 h. Fixed cells were stained with rhodamine-
phalloidin. Bar, 20 μm.
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cells. Kymograph analysis of time-lapse sequences perpendicular 
to the stress fibers indicated that thin stress fiber bundles in 
moesin shRNA cells displayed increased lateral movement com-
pared with thick stress fiber bundles in control cells, as indicated 
by continuous, relatively horizontal lines across the kymographs 
(Figure 5D). These data indicate that moesin promotes the 
FiGuRE 5: Moesin shRNA knockdown impairs actin stress fiber dynamics during TGF-β–induced EMT. (A) Images of 
WT, control shRNA, and moesin shRNA NMuMG cells expressing LifeAct-GFP and treated with TGF-β for 48 h. Images 
were acquired every 1 min for 1 h by spinning disk confocal time-lapse microscopy using a 60× objective (see 
Supplemental Videos S6 and S7). Bar, 20 μm. (B) Boxed regions in A magnified and shown as montages of images that 
were captured every 12 min. Bar, 20 μm. (C) Quantitative analysis of actin stress fiber thickness. The number of cells 
having mostly thick, intermediate or mixed, or mostly thin stress fibers were counted and expressed as percentage of 
the total number of cells counted. Data shown are from two independent experiments, for which n was between 46 and 
51 for each cell type. (D) Kymographs of regions in A marked with yellow or cyan arrows, showing the stability of stress 
fibers over time.
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assembly, organization, and stability of thick, bundled actin stress 
fibers in transdifferentiated cells.
Suppressing moesin expression during EMT limits 
relocalization of CD44, α-SMA, and p-MLC and the 
autophosphorylation of focal adhesion kinase
Additional cytoskeleton-associated changes that occur during TGF-
β–induced EMT include increased expression of extracellular matrix 
proteins and acquisition of cell–substrate adhesions and cell con-
tractility (Maeda et al., 2005). CD44, a cell surface receptor for extra-
cellular matrix components that regulates cell adhesion and migra-
tion and binds to ERM proteins (Fehon et al., 2010), had increased 
abundance in wild-type and control shRNA cells treated with TGF-β 
(Figure 6A), consistent with recent findings that increased CD44 is a 
marker for EMT (Mani et al., 2008). In addition, CD44 relocalized 
from cell–cell adhesions in the absence of TGF-β to large dorsal 
membrane protrusions and numerous smaller membrane microex-
tensions after 48 h with TGF-β. As expected, CD44 showed a high 
degree of colocalization with moesin in both the absence and pres-
ence of TGF-β (Figure 6B). Suppressing moesin expression slightly 
attenuated the increase in CD44 expression during EMT (Figure 6A); 
however, more markedly, it reduced the abundance of CD44 in dor-
sal protrusions compared with wild-type and control cells (Figure 
6C), although CD44 remained localized to plasma membrane mi-
croextensions. Consistent with moesin regulating a cell–substrate 
adhesion protein, the increased abundance of autophosphorylated 
focal adhesion kinase (p-FAK) seen in wild-type and control shRNA 
cells, and previously reported for TGF-β-induced EMT (Nakamura 
et al., 2001), was markedly reduced in moesin shRNA cells (Figure 
6D). The abundance of total FAK was unchanged during EMT in 
wild-type and moesin shRNA cells. Suppressing moesin expression 
had no effect on the increased abundance of fibronectin during 
EMT (Figure 6D) and it did not alter the size and number of paxillin-
labeled focal adhesions compared with controls (Supplemental Fig-
ure S3), although our data do not rule out possible dual effects of 
moesin on focal adhesion assembly and turnover. However, clear 
effects of moesin on CD44 localization and p-FAK suggest that its 
increased expression contributes to cell–substrate adhesions during 
EMT.
To compare our findings with established effects of ROCK ac-
tivity on cell–substrate adhesions, we confirmed that cotreating 
wild-type cells with Y-27632 blocked TGF-β–induced increases in 
p-FAK and focal adhesion size and abundance but not fibronectin 
expression (Figure 6D and Supplemental Figure S3). Y-27632 also 
blocked an increase in the abundance of phosphorylated moesin. 
In wild-type cells treated with TGF-β, there was a time-dependent 
increase in phosphorylated moesin, with a 5.0-fold increase after 
48 h, compared with a 2.0-fold increase in total moesin protein 
(Figure 6D; phosphorylated moesin is the lower band recognized 
by phosphorylated ERM [p-ERM] antibodies). Phosphorylation of 
moesin increases its actin cross-linking ability, which these data 
suggest may function in promoting EMT. Although Y-27632 pre-
vented the increase in phosphorylated moesin, consistent with 
ERM proteins being substrates for ROCK (Matsui et al., 1998; 
Oshiro et al., 1998; Shaw et al., 1998), it had no effect on the in-
creased abundance of total moesin protein. Despite the view that 
Rho, ROCK, and ERM proteins function in the same pathways 
regulating actin cytoskeleton organization (Mackay et al., 1997; 
Takahashi et al., 1997; Shaw et al., 1998; Speck et al., 2003; Lee et 
al., 2004), our data suggest that a transcriptional program for in-
creased moesin expression during EMT is independent of ROCK 
activity.
Another notable cytoskeleton-associated change that occurs 
during TGF-β–induced EMT is increased expression of α-SMA 
(Masszi et al., 2003; Cho and Yoo, 2007). Immunoblot analysis con-
firmed a modest increase in the abundance of α-SMA in wild-type 
and control shRNA cells treated with TGF-β (Figure 6D), as previ-
ously described for NMuMG cells (Valcourt et al., 2005). The in-
crease in α-SMA expression was blocked in wild-type cells cotreated 
with Y-27632, similar to previous findings (Cho and Yoo, 2007), but 
not in moesin shRNA cells (Figure 6D). A more distinct change in 
α-SMA during EMT of NMuMG cells was its relocalization from a 
diffuse distribution in the cytoplasm to prominent patches at the 
cell cortex (Figure 6E). In moesin shRNA cells, however, the abun-
dance of α-SMA in cortical patches was markedly reduced com-
pared with wild-type and control cells (Figure 6E), indicating that 
relocalization was incomplete. To our knowledge, cortical clustering 
of α-SMA has not previously been reported during EMT, but it may 
be a conserved feature because we also noted relocalization of 
α-SMA to cortical patches during EMT of A549 cells (Supplemental 
Figure S4A).
We further characterized these cortical α-SMA patches in trans-
differentiated NMuMG cells by showing that although they did not 
localize at actin stress fibers or label with phalloidin (Figure 7A), they 
were still present after Triton extraction to remove soluble proteins 
prior to fixation and immunolabeling, which indicates cytoskeleton 
association (Supplemental Figure S4B). Moreover, a subset colocal-
ized with moesin, as indicated by immunolabeling for moesin and 
for phosphorylated ERM proteins (Figure 7B). Also colocalizing with 
a subset of α-SMA patches were the p34Arc subunit of the Arp2/3 
complex that binds and nucleates actin filaments and p-MLC (Figure 
7B). Association with p34Arc and p-MLC suggested that cortical 
α-SMA patches could be regulated by actomyosin contractility. To 
confirm this, we treated transdifferentiated cells with Y-27632 or 
with blebbistatin, a myosin II inhibitor, which disassembled actin 
stress fibers and completely abolished cortical α-SMA localization 
(Figure 7A). In addition, treating transdifferentiated cells with the 
microtubule-depolymerizing agent nocodazole, which stimulates 
contractility, increased the number and thickness of actin stress fi-
bers and the number of cortical α-SMA patches (Figure 7A). To-
gether, these findings indicate that moesin regulates a contractility-
dependent clustering of α-SMA at the cell cortex that we predict is 
necessary for a complete EMT.
To further test a role for moesin in contractility-dependent corti-
cal clustering, we recorded time-lapse movies of wild-type cells 
transiently expressing moesin-GFP. In transdifferentiated cells, we 
also observed clusters of moesin-GFP enriched at membrane pro-
trusions that clearly formed as a result of contractile intracellular 
movements and that were reminiscent of α-SMA patches (Supple-
mental Video S8, right, arrows). In contrast, contractile moesin clus-
ters were not evident in cells maintained in the absence of TGF-β, in 
which moesin-GFP localized to highly dynamic membrane patches 
and filamentous structures (Supplemental Video S8, left). We also 
asked whether the localization of p-MLC changes during transdif-
ferentiation and whether this is dependent on increased moesin ex-
pression. In wild-type and control shRNA cells maintained in the 
absence of TGF-β, p-MLC was distributed diffusely in the cytoplasm 
and enriched at cell–cell adhesions. After 48 h with TGF-β, p-MLC 
was predominantly localized along actin stress fibers and in small 
cortical aggregates near the dorsal cell surface (Figure 8A). Sup-
pressing moesin expression during EMT had no obvious effect on 
p-MLC localized at actin stress fibers; however, it markedly reduced 
the abundance of cortical p-MLC aggregates. Furthermore, p-MLC 
colocalized with moesin at a subset of membrane protrusions in 
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transdifferentiated wild-type cells (Figure 8B). Control cells treated 
with TGF-β also had increased abundance of p-MLC, as indicated 
by immunoblotting, which was not different in cells with suppressed 
moesin expression (unpublished data). These data confirm that in-
creased moesin expression during EMT is necessary for the cortical 
localization of p-MLC and α-SMA, which is associated with the cy-
toskeleton and regulated by actomyosin contractility.
Suppressing moesin expression during EMT increases 
cell migration in monolayer wound healing but decreases 
cell invasion
In addition to inducing changes in cell morphology, actin cytoskel-
eton organization, and adhesions, TGF-β promotes increased cell 
migration and invasion, which contribute to the progression of met-
astatic cancers (Yilmaz and Christofori, 2009). To determine whether 
FiGuRE 6: Moesin shRNA knockdown impairs relocalization of CD44 and α-SMA and attenuates increased 
phosphorylation of FAK during TGF-β–induced EMT. (A) Immunoblots of lysates from NMuMG cells treated with TGF-β, 
showing changes in expression of CD44 during EMT. Wild-type, control shRNA, and moesin shRNA cells were 
maintained in the absence (−) or presence (+) of TGF-β for 48 h. Blots were probed with antibodies for E-cadherin, 
CD44, and moesin. Blots were also probed with antibodies for β-actin as a loading control. (B, C) CD44 immunolabeling 
showing relocalization during EMT. Cells were maintained in the absence (−) or presence (+) of TGF-β for 48 h. (B) 
Wild-type cells were fixed and immunolabeled with antibodies for CD44 and moesin. Bar, 20 μm. (C) Control shRNA and 
moesin shRNA cells were fixed and immunolabeled with antibodies for CD44. The projections show total CD44 
immunolabeling for TGF-β–treated cells that were imaged at multiple Z-sections. Bar, 20 μm. (D) Immunoblots of lysates 
from cells treated with TGF-β, showing changes in expression of cytoskeleton-associated proteins during EMT. 
Wild-type, control shRNA, and moesin shRNA cells were maintained in the absence (−) or presence (+) of TGF-β for 
24 or 48 h. Also shown are wild-type cells cotreated with the ROCK inhibitor Y-27632. Blots were probed with 
antibodies for E-cadherin, fibronectin, p-FAK, FAK, and α-SMA and with antibodies for p-ERM or pan-ERM (ERM). Blots 
were also probed with antibodies for β-actin and α-tubulin as loading controls. (E) Immunolabeling of cells showing 
relocalization of α-SMA during EMT. Wild-type, control shRNA, and moesin shRNA cells were maintained in the absence 
(−) or presence (+) of TGF-β for 48 h. Fixed cells were immunolabeled with antibodies for α-SMA. The projections show 
total α-SMA immunolabeling for TGF-β–treated cells that were imaged at multiple Z-sections. Bar, 20 μm.
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moesin regulates the migration of transdifferentiated cells, we 
wounded a monolayer of cells treated with TGF-β for 48 h and mon-
itored wound closure by time-lapse microscopy (Figure 9, A and B, 
and Supplemental Videos S9 and S10). Wild-type and control shRNA 
cells migrated at similar rates of 10.39 ± 0.84 and 12.09 ± 0.95 μm/h, 
respectively (mean ± SEM over 20 h; n = 4), consistent with previous 
reports (Lamouille and Derynck, 2007). In contrast, moesin-shRNA 
cells migrated significantly faster, at a rate of 16.50 ± 1.77 μm/h 
(n = 4; p < 0.05), which was a 1.4-fold increase compared with con-
trol shRNA cells.
In contrast to increased migration with monolayer wounding, 
suppressing moesin expression decreased invasion of transdifferen-
tiated cells. Wild-type, control shRNA, and moesin shRNA cells were 
treated with TGF-β for 48 h and then seeded onto Matrigel base-
ment membrane matrix–coated filters, after which cell invasion was 
determined at 21 h. Wild-type and control shRNA cells invaded the 
matrix and migrated through the filters at similar numbers (Figure 
9C). However, moesin shRNA cells had a significant 1.8-fold decrease 
in invasion compared with control shRNA cells (p < 0.001). Thus, 
although transdifferentiated cells with suppressed moesin expres-
sion had increased wound-healing migration, their ability to invade a 
basement membrane matrix was significantly impaired. These differ-
ences may reflect reduced tensional force from thinner, less stable 
actin stress fibers in moesin shRNA cells compared with force gener-
ated from thicker, more stable fibers in control cells. Taken together, 
our findings indicate that moesin regulates actin cytoskeleton re-
modeling and morphological changes for TGF-β–induced EMT of 
NMuMG cells, which in turn modulates cell migration and invasion.
DISCUSSION
EMT is driven by changes in gene expression and cell morphology 
that promote migration and invasion during normal development 
and the progression of diseases such as metastatic cancer and fibro-
sis. Despite notable changes in actin cytoskeleton architecture dur-
ing EMT (Miettinen et al., 1994; Zavadil et al., 2001; Masszi et al., 
2003; Brown et al., 2004), how this occurs in real time, how it con-
tributes to morphological changes, and whether it is regulated 
by changes in gene expression remain relatively unknown. Actin 
FiGuRE 7: Cortical α-SMA localization is regulated by actomyosin contractility and is associated with moesin. 
(A) F-actin staining and α-SMA immunolabeling, showing α-SMA localization in the presence of pharmacological 
inhibitors that regulate actomyosin contractility. Wild-type cells were maintained in the presence of TGF-β for 48 h and 
then cotreated for 1 h with the ROCK inhibitor Y-27632, the myosin II inhibitor blebbistatin, or the microtubule-
depolymerizing agent nocodazole. Fixed cells were labeled with rhodamine-phalloidin and with antibodies for α-SMA. 
The projections show total α-SMA immunolabeling for cells that were imaged at multiple Z-sections. Bar, 20 μm. 
(B) Wild-type NMuMG cells treated with TGF-β for 48 h immunolabeled for α-SMA and colabeled with antibodies for 
moesin, p-ERM, p-MLC, and the p34 subunit of the Arp2/3 complex (p34Arc). Bars, 20 μm.
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regulatory genes are among the most highly up-regulated groups 
during TGF-β-induced EMT (Zavadil et al., 2001; Xie et al., 2003; 
Valcourt et al., 2005; Keshamouni et al., 2006; Safina et al., 2009; 
Lenferink et al., 2010); however, the functional significance of this 
regulation is largely unknown (Mori et al., 2009). We used LifeAct-
GFP, a recently developed fluorescent reporter for F-actin (Riedl 
et al., 2008), to reveal in real time the progressive changes in actin 
filament organization and properties that are consistent with tran-
scriptional regulation rather than rapid signaling events.
Our findings with three distinct epithelial cell types suggest a 
conserved and significant increase in moesin expression during 
EMT. Moesin expression also increases during TGF-β–induced EMT 
of keratinocytes (Zavadil et al., 2001; Valcourt et al., 2005), mam-
mary epithelial cells (Valcourt et al., 2005), and lung carcinoma cells 
(Keshamouni et al., 2006), further suggesting a conserved event. 
However, the functional significance of increased moesin expression 
during EMT has not been reported. Moesin and the other ERM pro-
teins ezrin and radixin regulate actin cytoskeleton remodeling for 
dynamic cellular processes, including cell morphogenesis, adhe-
sion, and migration (Fievet et al., 2007; Fehon et al., 2010). ERM 
proteins also regulate epithelial cell integrity and formation of the 
apical membrane domain (Gautreau et al., 2000; Speck et al., 2003; 
Saotome et al., 2004). Although ERM proteins are known to pro-
mote epithelial plasticity for morphogenesis and migration, their 
role in EMT is not clearly established. Binding of moesin and ezrin to 
the small, mucin-like transmembrane glycoprotein podoplanin was 
shown to be necessary for EMT of MDCK cells by inducing activa-
tion of RhoA (Martin-Villar et al., 2006), although this effect was not 
noted to be dependent on changes in ERM protein expression. In 
addition, recent work shows that moesin promotes actin remodeling 
during tumor necrosis factor-α–induced EMT of retinal pigment epi-
thelial cells (Takahashi et al., 2010). Analyses of our LifeAct-GFP 
time-lapse movies indicate that increased moesin expression is nec-
essary for dynamic actin filament remodeling during EMT, including 
filament bundling, organization, and stability.
We also found a moesin-dependent relocalization of CD44, 
α-SMA, and p-MLC, and increased autophosphorylation of FAK dur-
ing EMT. High expression of CD44 is emerging as a marker of TGF-
β–induced EMT and a feature shared by epithelial stem cells (Mani 
et al., 2008), and repressed CD44 expression is associated with tumor 
suppression (Godar et al., 2008). In addition, recent findings suggest 
that a CD44–ERM linkage at the cell cortex might be an important 
step in reorganization of the actin cytoskeleton during cytokine-in-
duced EMT of human lung carcinoma cells (Buckley et al., 2011). Our 
data indicate that increased moesin expression is necessary for the 
relocalization of CD44 at dorsal membrane protrusions in transdiffer-
entiated cells. Increased moesin expression is also necessary for relo-
calization of α-SMA during EMT to cortical patches that contain 
moesin, p34Arc, and p-MLC but not F-actin. Moreover, cortical α-SMA 
patches are dependent on actomyosin contractility, as indicated by 
their decreased abundance after inhibiting myosin activity. In addition, 
dynamic clustering of moesin-GFP–enriched membrane protrusions 
occurs as a result of contractile intracellular movements in transdiffer-
entiated cells. Together, our data suggest of model of moesin-depen-
dent assembly of contractile elements at cortical adhesion sites as a 
required mechanism for actin filament remodeling, actin stress fiber 
stability, and a complete morphological transition during EMT.
Our data also reveal new insights on the regulation and function 
of moesin and differences compared with other ERM proteins. First, 
increased moesin expression during EMT is independent of ROCK 
activity, despite ROCK-dependent increases in phosphorylated 
moesin abundance and shared effects of ROCK and moesin in pro-
moting actin filament remodeling. Second, the robust increase in 
moesin expression during EMT is not seen for ezrin or radixin. More-
over, ezrin abundance is not altered in moesin shRNA cells, which 
indicates the phenotype of disrupted actin filament remodeling, de-
creased α-SMA cortical patches, and attenuated cell invasion of 
these cells is selectively moesin dependent. A previous view was 
that ERM proteins have redundant functions, based on their high 
sequence homology and tissue-specific expression, and the lack of 
morphological or functional effects when a single ERM protein is 
inactivated in cells expressing two or all three ERM proteins (Doi 
et al., 1999). However, a revised view of nonredundant functions is 
supported by mouse models of gene inactivation revealing essen-
tial functions for ezrin and radixin in tissues expressing only a single 
ERM protein (Kikuchi et al., 2002; Kitajiri et al., 2004; Saotome et al., 
2004; Tamura et al., 2005). In addition, recent studies show distinct 
functions for ezrin and moesin for leukocyte immunological synapse 
formation (Ilani et al., 2007) and in melanoma cells during invasion 
and lung colonization (Estecha et al., 2009). Our findings that sup-
pressing moesin expression has functional effects during EMT of 
NMuMG cells that also express ezrin and radixin further support the 
revised view that ERM proteins have nonredundant functions.
FiGuRE 8: Moesin shRNA knockdown impairs relocalization of 
phosphorylated MLC to cortical patches during TGF-β–induced EMT. 
(A) Immunolabeling of NMuMG cells showing relocalization of p-MLC 
during EMT. Wild-type, control shRNA, and moesin shRNA cells were 
maintained in the absence or presence of TGF-β for 48 h. Fixed cells 
were immunolabeled with antibodies for MLC-pS19. Bar, 20 μm. 
(B) Colocalization p-MLC and moesin at cortical patches. Wild-type 
cells treated with TGF-β for 48 h immunolabeled for p-MLC and 
colabeled with antibodies for moesin. Bar, 20 μm.
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The significance of increased ezrin expression we observed dur-
ing EMT of NMuMG cells is unclear. Although this was not seen with 
EMT of MCF-10A or A549 cells, decreased expression of ezrin oc-
curs during EMT of peritoneal mesothelial cells (Vargha et al., 2006) 
and retinal pigment epithelial cells (Takahashi et al., 2010). In addi-
tion, fibroblasts deficient for the EMT-inducing transcription factor 
Snail1 have increased expression of ezrin and decreased expression 
of moesin and are unable to invade a three-dimensional extracellu-
lar matrix (Rowe et al., 2009). Hence, ERM protein switching with 
opposing changes in ezrin and moesin may be a feature of EMT of 
some cell types. Decreased ezrin expression during EMT could re-
flect a distinct transdifferentiation program and perhaps a require-
ment to achieve epithelial plasticity. This 
would be analogous to inactivation of 
moesin being necessary for cytoskeletal re-
modeling during immunological synapse 
formation in leukocytes (Faure et al., 2004; 
Ilani et al., 2007).
The ERM protein switching we report 
during TGF-β–induced EMT may also be a 
feature of the early stages of breast cancer 
progression, consistent with the relative 
abundance of ezrin being higher in noninva-
sive, more epithelial-like breast cancer cells, 
whereas the relative abundance of moesin is 
higher in invasive, more mesenchymal-like 
breast cancer cells (Ostapkowicz et al., 
2006). Changes in expression of ERM pro-
teins may also contribute to the progression 
of fibrosis. Fibrotic pulmonary fibroblasts 
have increased expression of ezrin and 
moesin compared with normal pulmonary 
fibroblasts (Shi-Wen et al., 2004), and after 
acute liver injury, fibrosis of hepatic stellate 
cells is decreased in moesin-null mice 
(Okayama et al., 2008). The critical role of 
actin cytoskeleton remodeling in the pro-
gression of diseases such as metastatic can-
cer and fibrosis underscores the importance 
of understanding its complex regulation, 
which we show for EMT is determined by 
increased moesin expression and a moesin-
dependent assembly of contractile elements 
at the cell cortex.
MATERIALS AND METHODS
Antibodies
Primary antibodies to E-cadherin (clone 36) 
and FAK (clone 77) were purchased from BD 
Transduction Laboratories (Lexington, KY). 
Primary antibodies to N-cadherin, ezrin, 
moesin (Q480), pan-ERM, phospho-ERM, 
and phospho-MLC (Ser19; mouse monoclo-
nal) were purchased from Cell Signaling 
Technology (Beverly, MA). Primary antibod-
ies to radixin, fibronectin, α-SMA (clone 
1A4), and α-tubulin (clone DM1A) were pur-
chased from Sigma-Aldrich (St. Louis, MO). 
Primary antibody to CD44 (clone A020) was 
purchased from Calbiochem (La Jolla, CA). 
Primary antibody to phospho-MLC (S19/
S20; rabbit polyclonal) was purchased from 
Rockland Immunochemicals (Gilbertsville, PA). Primary antibodies to 
p34-Arc/ARPC2 and β-actin (clone C4) were purchased from Milli-
pore (Billerica, MA). Primary antibodies to FAK-pY397 and second-
ary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 568 
were purchased from Invitrogen (Carlsbad, CA). Secondary antibod-
ies conjugated to peroxidase were purchased from Jackson Immu-
noResearch Laboratories (West Grove, PA).
Cell culture, treatments, and transfections
NMuMG normal mouse mammary gland epithelial cells (obtained 
from R. Derynck, University of California, San Francisco) and A549 
human lung adenocarcinoma cells (obtained from H. Chapman, 
FiGuRE 9: Moesin shRNA knockdown increases cell migration but decreases cell invasion 
during EMT. (A) Images of WT, control shRNA, and moesin shRNA NMuMG cells treated with 
TGF-β for 48 h and migrating at the indicated times after monolayer wounding. Images were 
acquired by time-lapse microscopy for 20 h, using a 10× objective. Bar, 200 μm. See 
Supplemental Videos S9 and S10. (B) Quantitative analysis of wound-healing migration of cells in 
A. Wound areas were measured every 4 h for a total of 20 h. Migratory rates were determined 
from the total decrease in wound area after 20 h. Data shown are means ± SEM of four 
independent experiments. Asterisks indicate significant difference between moesin shRNA and 
control shRNA cells. *p < 0.05 by one-way ANOVA followed by Newman–Keuls multiple 
comparisons post test. (C) Quantification of WT, control shRNA, and moesin shRNA cells treated 
for 48 h with TGF-β and invading a Matrigel matrix for 21 h. Data shown are means ± SEM of at 
least five membranes from three independent cell preparations. **p < 0.01; ***p < 0.001; n.s., 
not significant by one-way ANOVA followed by Newman–Keuls multiple comparisons post test.
4762 | J. Haynes et al. Molecular Biology of the Cell
blocked in 5% milk or 3% BSA, incubated with primary antibodies 
for 1 h or overnight, and incubated with peroxidase-conjugated sec-
ondary antibodies for 45 min. Bound antibodies were detected us-
ing enhanced chemiluminescence (PerkinElmer, Waltham, MA). 
Semiquantitative densitometric analysis of anti-ezrin and anti-moesin 
immunoblots from three independent experiments was performed 
using ImageJ software (National Institutes of Health, Bethesda, MD). 
The values for ezrin and moesin protein levels were normalized us-
ing β-actin as a loading control.
qPCR
RNA was extracted from NMuMG cells using the RNeasy Mini Kit 
(Qiagen, Valencia, CA), and first-strand cDNA was synthesized from 
total RNA using iScript reverse transcriptase (Bio-Rad Laboratories, 
Hercules, CA). cDNA was amplified using iQ SYBR Green Supermix 
(Bio-Rad Laboratories) and detected on a CFX96 Real-Time PCR 
detection system (Bio-Rad Laboratories). Quantitative analysis of 
ezrin, moesin, and radixin gene expression from at least three inde-
pendent experiments was performed using CFX Manager software 
(Bio-Rad Laboratories) and the ribosomal protein gene Rpl19 for 
normalization. Primers specific for mouse ezrin, moesin, and radixin 
cDNA were obtained from Qiagen (NM_009510, NM_010833, and 
NM_009041, respectively). The data were statistically analyzed us-
ing one-way analysis of variance (ANOVA) followed by Dunnett’s 
multiple comparison post test (Prism 4; GraphPad Software, La 
Jolla, CA).
immunolabeling and image acquisition
NMuMG cells grown on glass coverslips were washed three times 
with PBS at room temperature, fixed with 4% formaldehyde in PBS 
for 12 min, permeabilized with 0.5% Triton X-100 in PBS for 10 min, 
and then blocked with 3% BSA in PBS for 30 min or overnight. Fixed 
cells were incubated with primary antibodies for 1 or 2 h, washed 
with PBS, and incubated with fluorophore-conjugated secondary 
antibodies for 45 min. Fixed cells were also incubated with rhod-
amine-conjugated phalloidin (Invitrogen) for 10 min to stain F-actin 
and with Hoechst 33342 (Invitrogen) for 10 min to stain nuclei. For 
plasma membrane labeling, cells were incubated with 4 μg/ml 
Oregon Green 488–conjugated wheat germ agglutinin (Invitrogen) 
in PBS for 10 min at 37°C prior to fixation. Coverslips were mounted 
on slides with ProLong Gold antifade reagent (Invitrogen). Cells 
were imaged using a 63× Plan-Apochromat/1.40 or a 40× EC Plan-
Neofluar/1.30 oil immersion objective on an inverted laser-scanning 
confocal microscope (LSM510 META; Carl Zeiss, Thornwood, NY), 
and images were captured using Zeiss software (LSM 510 Meta 4.2 
Software). Z-Series projections represent confocal images combined 
from 16 optical sections acquired at 0.3-μm intervals.
Quantification of elongated cell morphology
Measurements of TGF-β–treated NMuMG cells were made using im-
ages of cells that were stained for F-actin and nuclei and were ac-
quired using a 40× objective. The lengths of the major and minor cell 
axes were measured using Zeiss software (Zeiss LSM Image Browser). 
The ratios of the major axis to the minor axis of cells were used to 
determine the degree of elongated cell morphology. For each ex-
periment, between 30 and 40 cells of each cell type were measured. 
The data were statistically analyzed using one-way ANOVA followed 
by Dunnett’s multiple comparison post test (Prism 4).
Spinning disk confocal and time-lapse microscopy
NMuMG cells grown on glass coverslips were imaged at 37°C 
using a 40× Plan-fluor ELWD/0.6 air objective (phase contrast) or 
University of California, San Francisco) were maintained in DME me-
dium (4.5 g/l glucose) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen), 100 U/ml penicillin, and 100 μg/ml streptomycin. 
Growth medium for NMuMG cells was also supplemented with 
10 μg/ml insulin (Sigma-Aldrich). MCF-10A human mammary epi-
thelial cells (obtained from J. Debnath, University of California, San 
Francisco) were maintained in DME/F-12 medium (4.5 g/l glucose) 
supplemented with 5% horse serum (Invitrogen), 10 μg/ml insulin, 
20 ng/ml epidermal growth factor (PeproTech, Rocky Hill, NJ), 
0.5 μg/ml hydrocortisone (Sigma-Aldrich), 100 ng/ml cholera toxin 
(Sigma-Aldrich), 100 U/ml penicillin, and 100 μg/ml streptomycin. 
293TA human embryonic kidney cells were maintained in DME me-
dium (4.5 g/l glucose) supplemented with 10% tetracycline-free FBS 
(Clontech, Mountain View, CA) and 110 mg/l sodium pyruvate. All 
cell lines were maintained at 37°C in 5% CO2.
Unless otherwise indicated, NMuMG cells were treated with 
5 ng/ml recombinant human TGF-β (in 10 mM citric acid, pH 3; 
PeproTech) for 48 h to induce EMT. MCF-10A and A549 cells were 
treated with 10 ng/ml TGF-β for 3–5 d or for 1–2 d in serum-free 
small airway basal medium (Lonza, Basel, Switzerland), respec-
tively. To inhibit TGF-β type I receptor signaling, cells were treated 
with 5 μM SB431542 (in dimethyl sulfoxide [DMSO]; Sigma-
Aldrich). To inhibit Rho kinase (ROCK), cells were treated with 5 μM 
Y-27632 (in dH2O; Calbiochem) for 45 min before TGF-β treat-
ment. For short-term treatments with pharmacological inhibitors, 
cells were incubated with 10 μM Y-27632, 5 μM blebbistatin (in 
DMSO; Calbiochem), or 5 μM nocodazole (in DMSO; Calbiochem) 
for 1 h after 48 h with TGF-β. Cells were transfected using Lipo-
fectamine 2000 (Invitrogen), according to the manufacturer’s pro-
tocol. Transfected cells were seeded on glass coverslips and cul-
tured for 2–3 d before experimental analysis.
DNA constructs, lentivirus production, and generation 
of stable cell lines
The plasmid containing mEGFP-N1-LifeAct sequence was kindly 
provided by Roland Wedlich-Sölder (Max Planck Institute of Bio-
chemistry, Martinsried, Germany). The moesin-GFP construct was 
kindly provided by Francisco Sanchez-Madrid (Universidad 
Autonoma de Madrid, Madrid, Spain). Lentiviral plasmids (pLKO.1-
puro) containing shRNA sequences to mouse moesin were obtained 
from Sigma-Aldrich (NM_010833, MISSION shRNA). MISSION Non-
Target shRNA Control Vector (Sigma-Aldrich) was used as a control. 
Lentiviruses were produced in 293TA packaging cells using the 
Lenti-X HT Packaging System (Clontech), according to the manufac-
turer’s protocol. For lentiviral transduction, NMuMG cells were in-
fected with lentivirus expressing control or moesin shRNA in growth 
medium supplemented with 4 μg/ml Polybrene (Sigma-Aldrich). 
Stable clonal cell lines were selected with 10 μg/ml puromycin (Cell-
gro; Mediatech, Manassas, VA) and were maintained in 2.5 μg/ml 
puromycin.
immunoblot analysis
Immunoblot analyses were performed using lysates from cells lysed 
in ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 
mM EDTA, 1% Triton X-100, 0.5% NaDOC, 0.1% SDS, and protease 
inhibitors) containing phosphatase inhibitors (50 mM NaF, 1 mM 
NaVO4, 1 mM ethylene glycol tetraacetic acid, 10 mM sodium pyro-
phosphate, 1 mM glycerol phosphate, and 10 nM calyculin A). Pro-
tein concentrations of clarified cell lysates were determined using a 
bicinchoninic acid protein assay kit (Pierce, Thermo Scientific, Rock-
ford, IL). Proteins (5–10 μg) were separated by SDS–PAGE and trans-
ferred to polyvinylidene fluoride membranes. Membranes were 
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as the average of seven different fields of view from the same mem-
brane. For each cell type, a total of at least five membranes were 
counted from three independent experiments. The data were statis-
tically analyzed using one-way ANOVA followed by Bonferroni’s 
multiple comparison post test (Prism 4).
a 60× Plan Apochromat TIRF/1.45 oil immersion objective (fluores-
cence) on an inverted microscope system (Nikon Eclipse TE2000 
Perfect Focus System; Nikon Instruments, Melville, NY), equipped 
with a spinning-disk confocal scanner unit (CSU10; Yokogawa, 
Newnan, GA), a 488-nm solid-state laser (LMM5; Spectral Applied 
Research, Richmond Hill, Canada), multipoint stage (MS-2000; Ap-
plied Scientific Instruments, Eugene, OR), a CoolSnap HQ2 cooled 
charge-coupled device (CCD) camera (Photometrics, Tucson, AZ), 
and camera-triggered electronic shutters controlled with NIS-Ele-
ments Imaging Software (Nikon). For short-term videos, cells were 
imaged after 48 h of TGF-β treatment in medium supplemented 
with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), pH 7.5, and images were captured every 1 min. For long-
term videos, cells were imaged after 1 h (phase contrast) or 6 h 
(fluorescence) of TGF-β treatment in medium supplemented with 
10 mM HEPES, pH 7.5, in 5% CO2, and images were captured ev-
ery 10 min. Images for presentation in figures and videos were pro-
cessed with a 2 × 2 Gaussian low-pass filter to reduce high-fre-
quency pixel noise, and an unsharp mask filter (7 × 7 kernel size; 
scaling factor 0.5 for short-term videos, or 13 × 13 kernel size; scal-
ing factor 0.7 for long-term videos) to enhance dim features using 
NIS-Elements Imaging Software.
in vitro wound-healing migration assays and 
time-lapse microscopy
Monolayers of NMuMG cells grown in six-well plates were wounded 
using a plastic pipette tip 48 h after the initiation of TGF-β treat-
ment, washed twice with serum-free medium, and replenished with 
fresh medium. Cells were imaged at 37°C in 5% CO2 using a 10× 
Hoffmann modulation objective on a Zeiss Axiovert S-100 micro-
scope. Images were captured every 15 min, beginning immedi-
ately after wounding and ending 20 h after wounding, using a Spot 
RT Slider cooled CCD camera (2.3.0; Diagnostic Instruments, Ster-
ling Heights, MI) operated with Openlab software (Improvision, 
PerkinElmer). Wound-area measurements were determined using 
ImageJ software. The area of a single wound was calculated as the 
average of three different cell-free areas from the same wound. 
The migratory rates were determined by the total decreased 
wound area from 0 h to 20 h after wounding. For each condition, 
wounds from four independent experiments were measured. The 
decreased wound areas for each time point were statistically ana-
lyzed using one-way ANOVA followed by Newman–Keuls multiple 
comparison post test (Prism 4).
Matrigel Transwell invasion assays
NMuMG cells grown in the presence of TGF-β for 48 h were resus-
pended in DME medium supplemented with 0.2% FBS and were 
seeded in the upper chamber onto rehydrated Growth Factor Re-
duced Matrigel Matrix–coated inserts (BD Biosciences, San Diego, 
CA). The lower chamber was filled with DME medium supplemented 
with 10% FBS, and the invasion chambers were incubated for 21 h 
at 37°C in 5% CO2. Noninvading cells were removed from the upper 
surface of the membrane with a cotton-tipped applicator. Cells were 
fixed with methanol for 5 min at −20°C, and nuclei were stained with 
Hoechst 33342 (Invitrogen) for 5 min. Membranes were mounted 
onto glass slides with Fluorescence Mounting Medium (Dako, 
Glostrup, Denmark). Cell nuclei were imaged using a 10× Plan-Neo-
fluar/0.3 air objective on a Zeiss Axiophot epifluorescence micro-
scope, and images were captured using a CoolSnap HQ2 camera 
operated by Micro-Manager software (University of California, San 
Francisco). Cells were counted using ImageJ software. The number 
of cells invading per field of view for one membrane was calculated 
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